Risk of rare heart inflammation may be higher after Moderna than Pfizer COVID vaccine
Authors: ry Van Beusekom | News Writer | CIDRAP News | Nov 08, 202 Myocarditis and pericarditis are rare after mRNA COVID-19 vaccination, but rates of the inflammatory heart conditions were twofold to threefold higher after receipt of the second dose of the Moderna vaccine than after the Pfizer/BioNTech formulation, suggests a head-to-head comparison in Canadian […]